The interactome of the Glucocorticoid receptor and its influence on the actions of Glucocorticoids in combatting inflammatory and infectious diseases

Microbiology and Molecular Biology Reviews

Volumn 80, Issue 2, 2016, Pages 495-522

  Petta, Ioanna ^a,b   Dejager, Lien ^a,b   Ballegeer, Marlies ^a,b   Lievens, Sam ^a,b   Tavernier, Jan ^a,b   De Bosscher, Karolien ^a,b   Libert, Claude ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CELL NUCLEUS RECEPTOR; CHAPERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN; STAT5 PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN CONJUGATING ENZYME; STAT PROTEIN;

ALTERNATIVE RNA SPLICING; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; CELL MEMBRANE; CELL NUCLEUS; CORTICOSTEROID THERAPY; CYTOPLASM; DEACETYLATION; DIMERIZATION; GENOMICS; HUMAN; INFECTION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PROTEIN ACETYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; T LYMPHOCYTE; ANIMAL; COMMUNICABLE DISEASES; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL NUCLEUS; COMMUNICABLE DISEASES; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; PROTEIN INTERACTION MAPS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 85009074700     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00064-15     Document Type: Review

References (274)

1. Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R. 2004. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 11(Suppl 1):S45-S55. http://dx.doi.org/10.1038/sj.cdd.4401456.
2. Rhen T, Cidlowski JA. 2005. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353:1711-1723. http://dx.doi.org/10.1056/NEJMra050541.
3. Ericson-Neilsen W, Kaye AD. 2014. Steroids: pharmacology, complications, and practice delivery issues. Ochsner J 14:203-207.
4. Rao NA, McCalman MT, Moulos P, Francoijs KJ, Chatziioannou A, Kolisis FN, Alexis MN, Mitsiou DJ, Stunnenberg HG. 2011. Coactivation of GRand NFKB alters the repertoireoftheir binding sites and target genes. Genome Res 21:1404-1416. http://dx.doi.org/10.1101/gr.118042.110.
5. Presman DM, Ogara MF, Stortz M, Alvarez LD, Pooley JR, Schiltz RL, Grontved L, Johnson TA, Mittelstadt PR, Ashwell JD, Ganesan S, Burton G, Levi V, Hager GL, Pecci A. 2014. Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor. PLoS Biol 12:e1001813. http://dx.doi.org/10.1371/journal.pbio.1001813.
6. Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D, Li M, Chambon P. 2011. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145:224-241. http://dx.doi.org/10.1016/j.cell.2011.03.027.
7. Lim HW, Uhlenhaut NH, Rauch A, Weiner J, Hubner S, Hubner N, Won KJ, Lazar MA, Tuckermann J, Steger DJ. 2015. Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo. Genome Res 25:836-844. http://dx.doi.org/10.1101/gr.188581.114.
8. Schiller BJ, Chodankar R, Watson LC, Stallcup MR, Yamamoto KR. 2014. Glucocorticoid receptor binds half sites as a monomer and regulates specific target genes. Genome Biol 15:418. http://dx.doi.org/10.1186/s13059-014-0418-y.
9. Miner JN, Yamamoto KR. 1991. Regulatory crosstalk at composite response elements. Trends Biochem Sci 16:423-426. http://dx.doi.org/10.1016/0968-0004 (91) 90168-U.
10. Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, Darimont BD, Garabedian MJ, Yamamoto KR. 2003. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci U S A 100:13845-13850. http://dx.doi.org/10.1073/pnas.2336092100.
11. Beck IM, Vanden Berghe W, Vermeulen L, Yamamoto KR, Haegeman G, De Bosscher K. 2009. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev 30:830-882. http://dx.doi.org/10.1210/er.2009-0013.
12. Stahn C, Buttgereit F. 2008. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 4:525-533. http://dx.doi.org/10.1038/ncprheum0898.
13. Pratt WB, Morishima Y, Murphy M, Harrell M. 2006. Chaperoning of glucocorticoid receptors. Handb Exp Pharmacol 2006:111-138.
14. Rosenfeld MG, Lunyak VV, Glass CK. 2006. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signaldependent programs of transcriptional response. Genes Dev 20:1405-1428. http://dx.doi.org/10.1101/gad.1424806.
15. Buttgereit F, Scheffold A. 2002. Rapid glucocorticoid effects on immune cells. Steroids 67:529-534. http://dx.doi.org/10.1016/S0039-128X (01) 00171-4.
16. Ng SS, Li A, Pavlakis GN, Ozato K, Kino T. 2013. Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications. PLoS One 8:e63587. http://dx.doi.org/10.1371/journal.pone.0063587.
17. McGee S, Hirschmann J. 2008. Use of corticosteroids in treating infectious diseases. Arch Intern Med 168:1034-1046. http://dx.doi.org/10.1001/archinte.168.10.1034.
18. Dieken ES, Miesfeld RL. 1992. Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis. Mol Cell Biol 12:589-597. http://dx.doi.org/10.1128/MCB.12.2.589.
19. Kumar R, Thompson EB. 2005. Gene regulation by the glucocorticoid receptor: structure: function relationship. J Steroid Biochem Mol Biol 94:383-394. http://dx.doi.org/10.1016/j.jsbmb.2004.12.046.
20. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE. 2002. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110:93-105. http://dx.doi.org/10.1016/S0092-8674 (02) 00817-6.
21. Glass CK, Rose DW, Rosenfeld MG. 1997. Nuclear receptor coactivators. Curr Opin Cell Biol 9:222-232. http://dx.doi.org/10.1016/S0955-0674 (97) 80066-X.
22. Zhou J, Cidlowski JA. 2005. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70:407-417. http://dx.doi.org/10.1016/j.steroids.2005.02.006.
23. Kino T, Su YA, Chrousos GP. 2009. Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci 66:3435-3448. http://dx.doi.org/10.1007/s00018-009-0098-z.
24. Lewis-Tuffin LJ, Cidlowski JA. 2006. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci 1069:1-9. http://dx.doi.org/10.1196/annals.1351.001.
25. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, Collins JB, Cidlowski JA. 2007. Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active. Mol Cell Biol 27:2266-2282. http://dx.doi.org/10.1128/MCB.01439-06.
26. Yudt MR, Jewell CM, Bienstock RJ, Cidlowski JA. 2003. Molecular origins for the dominant negative function of human glucocorticoid receptor beta. Mol Cell Biol 23:4319-4330. http://dx.doi.org/10.1128/MCB.23.12.4319-4330.2003.
27. Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA. 1999. The dominant negative activity of the human glucocorticoid receptor beta isoform Specificity and mechanisms of action. J Biol Chem 274:27857-27866.
28. Oakley RH, Webster JC, Jewell CM, Sar M, Cidlowski JA. 1999. Immunocytochemical analysis of the glucocorticoid receptor alpha isoform (GRalpha) using GRalpha-specific antibody. Steroids 64:742-751. http://dx.doi.org/10.1016/S0039-128X (99) 00059-8.
29. Webster JC, Oakley RH, Jewell CM, Cidlowski JA. 2001. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead tothe accumulationof the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci U S A 98:6865-6870. http://dx.doi.org/10.1073/pnas.121455098.
30. Oakley RH, Cidlowski JA. 2011. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissuespecific actionsofglucocorticoids. J Biol Chem 286:3177-3184. http://dx.doi.org/10.1074/jbc. R110.179325.
31. Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ, Chrousos GP, Szefler SJ, Leung DY. 1999. Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 159:1600-1604. http://dx.doi.org/10.1164/ajrccm.159.5.9804131.
32. Derijk RH, Schaaf MJ, Turner G, Datson NA, Vreugdenhil E, Cidlowski J, de Kloet ER, Emery P, Sternberg EM, Detera-Wadleigh SD. 2001. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 28:2383-2388.
33. Takeda K, Takeno S, Hirakawa K, Ishino T. 2010. Expression and distribution of glucocorticoid receptor isoforms in eosinophilic chronic rhinosinusitis. Auris Nasus Larynx 37:700-707. http://dx.doi.org/10.1016/j.anl.2010.03.005.
34. Piotrowski P, Burzynski M, Lianeri M, Mostowska M, Wudarski M, Chwalinska-Sadowska H, Jagodzinski PP. 2007. Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus. Folia Histochem Cytobiol 45:339-342.
35. Koga Y, Matsuzaki A, Suminoe A, Hattori H, Kanemitsu S, Hara T. 2005. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children. Pediatr Blood Cancer 45:121-127. http://dx.doi.org/10.1002/pbc.20308.
36. Schaaf MJ, Champagne D, van Laanen IH, van Wijk DC, Meijer AH, Meijer OC, Spaink HP, Richardson MK. 2008. Discovery of a functional glucocorticoid receptor beta-isoform in zebrafish. Endocrinology 149:1591-1599. http://dx.doi.org/10.1210/en. 2007-1364.
37. Hinds TD, Jr, Ramakrishnan S, Cash HA, Stechschulte LA, Heinrich G, Najjar SM, Sanchez ER. 2010. Discovery of glucocorticoid receptorbeta in mice with a role in metabolism. Mol Endocrinol 24:1715-1727. http://dx.doi.org/10.1210/me.2009-0411.
38. Rivers C, Levy A, Hancock J, Lightman S, Norman M. 1999. Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab 84:4283-4286. http://dx.doi.org/10.1210/jcem.84.11.6235.
39. Waters CE, Stevens A, White A, Ray DW. 2004. Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line. J Endocrinol 183:375-383. http://dx.doi.org/10.1677/joe.1.05804.
40. Beger C, Gerdes K, Lauten M, Tissing WJ, Fernandez-Munoz I, Schrappe M, Welte K. 2003. Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol 122:245-252. http://dx.doi.org/10.1046/j.1365-2141.2003.04426.x.
41. Thomas-Chollier M, Watson LC, Cooper SB, Pufall MA, Liu JS, Borzym K, Vingron M, Yamamoto KR, Meijsing SH. 2013. A naturally occurring insertion of a single amino acid rewires transcriptional regulation by glucocorticoid receptor isoforms. Proc Natl Acad Sci U S A 110:17826-17831. http://dx.doi.org/10.1073/pnas.1316235110.
42. Krett NL, Pillay S, Moalli PA, Greipp PR, Rosen ST. 1995. A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res 55:2727-2729.
43. Gaitan D, DeBold CR, Turney MK, Zhou P, Orth DN, Kovacs WJ. 1995. Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Mol Endocrinol 9:1193-1201. http://dx.doi.org/10.1210/mend.9.9.7491111.
44. de Lange P, Segeren CM, Koper JW, Wiemer E, Sonneveld P, Brinkmann AO, White A, Brogan IJ, de Jong FH, Lamberts SW. 2001. Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res 61:3937-3941.
45. Turner JD, Schote AB, Keipes M, Muller CP. 2007. A new transcript splice variant of the human glucocorticoid receptor: identification and tissue distribution of hGR delta 313-338, an alternative exon 2 transactivation domain isoform. Ann N Y Acad Sci 1095:334-341. http://dx.doi.org/10.1196/annals.1397.037.
46. Baker AC, Green TL, Chew VW, Tung K, Amini A, Lim D, Cho K, Greenhalgh DG. 2012. Enhanced steroid response of a human glucocorticoid receptor splice variant. Shock 38:11-17. http://dx.doi.org/10.1097/SHK.0b013e318257c0c0.
47. Tung K, Baker AC, Amini A, Green TL, Chew VW, Lim D, Nguyen ST, Yee KS, Cho K, Greenhalgh DG. 2011. Novel hyperactive glucocorticoid receptor isoform identified within a human population. Shock 36:339-344. http://dx.doi.org/10.1097/SHK.0b013e318228eca7.
48. Pratt WB, Galigniana MD, Morishima Y, Murphy PJ. 2004. Role of molecular chaperones in steroid receptor action. Essays Biochem 40:41-58. http://dx.doi.org/10.1042/bse0400041.
49. Vandevyver S, Dejager L, Libert C. 2012. On the trail of the glucocorticoid receptor: into the nucleus and back. Traffic 13:364-374. http://dx.doi.org/10.1111/j.1600-0854.2011.01288.x.
50. Pratt WB, Silverstein AM, Galigniana MD. 1999. A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37. Cell Signal 11:839-851. http://dx.doi.org/10.1016/S0898-6568 (99) 00064-9.
51. Hutchison KA, Stancato LF, Owens-Grillo JK, Johnson JL, Krishna P, Toft DO, Pratt WB. 1995. The 23-kDa acidic protein in reticulocyte lysate is the weakly bound component of the hsp foldosome that is required for assembly of the glucocorticoid receptor into a functional heterocomplex with hsp90. J Biol Chem 270:18841-18847. http://dx.doi.org/10.1074/jbc.270.32.18841.
52. Freeman BC, Felts SJ, Toft DO, Yamamoto KR. 2000. The p23 molecular chaperones act at a late step in intracellular receptor action to differentially affect ligand efficacies. Genes Dev 14:422-434.
53. Murphy PJ, Morishima Y, Kovacs JJ, Yao TP, Pratt WB. 2005. Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone. J Biol Chem 280:33792-33799. http://dx.doi.org/10.1074/jbc. M506997200.
54. Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, Nicchitta CV, Yoshida M, Toft DO, Pratt WB, Yao TP. 2005. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 18:601-607. http://dx.doi.org/10.1016/j.molcel.2005.04.021.
55. Kanelakis KC, Murphy PJ, Galigniana MD, Morishima Y, Takayama S, Reed JC, Toft DO, Pratt WB. 2000. hsp70 interacting protein Hip does not affect glucocorticoid receptor folding by the hsp90-based chaperone machinery except to oppose the effect of BAG-1. Biochemistry 39:14314-14321. http://dx.doi.org/10.1021/bi001671c.
56. Nelson GM, Prapapanich V, Carrigan PE, Roberts PJ, Riggs DL, Smith DF. 2004. The heat shock protein 70 cochaperone hip enhances functional maturation of glucocorticoid receptor. Mol Endocrinol 18:1620-1630. http://dx.doi.org/10.1210/me.2004-0054.
57. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J, Patterson C. 2001. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 3:93-96. http://dx.doi.org/10.1038/35050618.
58. Glickman MH, Ciechanover A. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373-428. http://dx.doi.org/10.1152/physrev. 00027.2001.
59. Galigniana MD, Harrell JM, O'Hagen HM, Ljungman M, Pratt WB. 2004. Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. J Biol Chem 279:22483-22489. http://dx.doi.org/10.1074/jbc. M402223200.
60. Schulke JP, Wochnik GM, Lang-Rollin I, Gassen NC, Knapp RT, Berning B, Yassouridis A, Rein T. 2010. Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS One 5:e11717. http://dx.doi.org/10.1371/journal.pone.0011717.
61. Holownia A, Mroz RM, Kolodziejczyk A, Chyczewska E, Braszko JJ. 2009. Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy. Eur J Med Res 14(Suppl 4):S108-S111.
62. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick TP, Pantoja C, Erle DJ, Yamamoto KR, Fahy JV. 2007. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A 104:15858-15863. http://dx.doi.org/10.1073/pnas.0707413104.
63. Pereira MJ, Palming J, Svensson MK, Rizell M, Dalenback J, Hammar M, Fall T, Sidibeh CO, Svensson PA, Eriksson JW. 4 June 2014. FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance. Metabolism http://dx.doi.org/10.1016/j.metabol.2014.05.015.
64. Kino T, Souvatzoglou E, De Martino MU, Tsopanomihalu M, Wan Y, Chrousos GP. 2003. Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway. J Biol Chem 278:25651-25656. http://dx.doi.org/10.1074/jbc. M302818200.
65. Wakui H, Wright AP, Gustafsson J, Zilliacus J. 1997. Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein. J Biol Chem 272:8153-8156. http://dx.doi.org/10.1074/jbc.272.13.8153.
66. Kim YS, Jang SW, Sung HJ, Lee HJ, Kim IS, Na DS, Ko J. 2005. Role of 14-3-3 eta as a positive regulator of the glucocorticoid receptor transcriptional activation. Endocrinology 146:3133-3140. http://dx.doi.org/10.1210/en. 2004-1455.
67. Galliher-Beckley AJ, Williams JG, Cidlowski JA. 2011. Ligandindependent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol Cell Biol 31:4663-4675. http://dx.doi.org/10.1128/MCB.05866-11.
68. Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995. http://dx.doi.org/10.1038/ni1112.
69. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801. http://dx.doi.org/10.1016/j.cell.2006.02.015.
70. Miettinen M, Sareneva T, Julkunen I, Matikainen S. 2001. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun 2:349-355. http://dx.doi.org/10.1038/sj.gene.6363791.
71. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088. http://dx.doi.org/10.1126/science.282.5396.2085.
72. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor2. J Immunol 163:1-5.
73. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ, Skerrett SJ, Beutler B, Schroeder L, Nachman A, Ozinsky A, Smith KD, AderemA. 2003. Acommon dominant TLR5 stopcodon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J Exp Med 198:1563-1572. http://dx.doi.org/10.1084/jem.20031220.
74. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-1103. http://dx.doi.org/10.1038/35074106.
75. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738. http://dx.doi.org/10.1038/35099560.
76. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303:1526-1529. http://dx.doi.org/10.1126/science.1093620.
77. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of singlestranded RNA. Science 303:1529-1531. http://dx.doi.org/10.1126/science.1093616.
78. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745. http://dx.doi.org/10.1038/35047123.
79. Kawai T, Akira S. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13:460-469. http://dx.doi.org/10.1016/j.molmed.2007.09.002.
80. Mogensen TH, Berg RS, Paludan SR, Ostergaard L. 2008. Mechanisms of dexamethasone-mediated inhibition of Toll-like receptor signaling induced by Neisseria meningitidis and Streptococcus pneumoniae. Infect Immun 76:189-197. http://dx.doi.org/10.1128/IAI.00856-07.
81. Baeuerle PA, Henkel T. 1994. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179. http://dx.doi.org/10.1146/annurev. iy.12.040194.001041.
82. McKay LI, Cidlowski JA. 1999. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 20:435-459. http://dx.doi.org/10.1210/edrv. 20.4.0375.
83. Zhong H, Voll RE, Ghosh S. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1:661-671. http://dx.doi.org/10.1016/S1097-2765 (00) 80066-0.
84. Ray A, Prefontaine KE. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A 91:752-756. http://dx.doi.org/10.1073/pnas.91.2.752.
85. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS, Jr. 1995. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol 15:943-953. http://dx.doi.org/10.1128/MCB.15.2.943.
86. De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G. 1997. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 94:13504-13509. http://dx.doi.org/10.1073/pnas.94.25.13504.
87. Han CW, Choi JH, Kim JM, Kim WY, Lee KY, Oh GT. 2001. Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-kappaB activation induced by tumour necrosis factor alpha. Rheumatology (Oxford) 40:267-273. http://dx.doi.org/10.1093/rheumatology/40.3.267.
88. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, Glass CK. 2005. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122:707-721. http://dx.doi.org/10.1016/j.cell.2005.06.029.
89. Luecke HF, Yamamoto KR. 2005. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev 19:1116-1127. http://dx.doi.org/10.1101/gad.1297105.
90. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT. 1995. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory actionof glucocorticoids. Mol Endocrinol 9:401-412. http://dx.doi.org/10.1210/mend.9.4.7659084.
91. Liden J, Delaunay F, Rafter I, Gustafsson J, Okret S. 1997. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J Biol Chem 272:21467-21472.
92. Murphy SH, Suzuki K, Downes M, Welch GL, De Jesus P, Miraglia LJ, Orth AP, Chanda SK, Evans RM, Verma IM. 2011. Tumor suppressor protein (p) 53, is a regulator of NF-kappaB repression by the glucocorticoid receptor. Proc Natl Acad Sci U S A 108:17117-17122. http://dx.doi.org/10.1073/pnas.1114420108.
93. Maas K, Westfall M, Pietenpol J, Olsen NJ, Aune T. 2005. Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis. Arthritis Rheum 52:1047-1057. http://dx.doi.org/10.1002/art.20931.
94. Yamanishi Y, Boyle DL, Green DR, Keystone EC, Connor A, Zollman S, Firestein GS. 2005. p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis. Arthritis Res Ther 7:R12-R18. http://dx.doi.org/10.1186/ar1448.
95. Sengupta S, Vonesch JL, Waltzinger C, Zheng H, Wasylyk B. 2000. Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. EMBO J 19:6051-6064. http://dx.doi.org/10.1093/emboj/19.22.6051.
96. Sengupta S, Wasylyk B. 2001. Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes Dev 15:2367-2380. http://dx.doi.org/10.1101/gad.202201.
97. Leis H, Page A, Ramirez A, Bravo A, Segrelles C, Paramio J, Barettino D, Jorcano JL, Perez P. 2004. Glucocorticoid receptor counteracts tumorigenic activity of Akt in skin through interference with the phosphatidylinositol 3-kinase signaling pathway. Mol Endocrinol 18:303-311. http://dx.doi.org/10.1210/me.2003-0350.
98. Widen C, Gustafsson JA, Wikstrom AC. 2003. Cytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cells. Biochem J 373:211-220. http://dx.doi.org/10.1042/bj20030175.
99. Rangarajan PN, Umesono K, Evans RM. 1992. Modulation of glucocorticoid receptor functionby protein kinase A. Mol Endocrinol 6:1451-1457. http://dx.doi.org/10.1210/mend.6.9.1435789.
100. Haske T, Nakao M, Moudgil VK. 1994. Phosphorylation of immunopurified rat liver glucocorticoid receptor by the catalytic subunit of cAMP-dependent protein kinase. Mol Cell Biochem 132:163-171. http://dx.doi.org/10.1007/BF00926925.
101. Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM. 2000. Cytoplasmic catalytic subunit of protein kinase A mediates crossrepression by NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A 97:11893-11898. http://dx.doi.org/10.1073/pnas.220413297.
102. McKay LI, Cidlowski JA. 1998. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 12:45-56. http://dx.doi.org/10.1210/mend.12.1.0044.
103. Herdegen T, Leah JD. 1998. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 28:370-490. http://dx.doi.org/10.1016/S0165-0173 (98) 00018-6.
104. Kassel O, Schneider S, Heilbock C, Litfin M, Gottlicher M, Herrlich P. 2004. A nuclear isoformofthe focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters. Genes Dev 18:2518-2528. http://dx.doi.org/10.1101/gad.322404.
105. Sousa AR, Lane SJ, Soh C, Lee TH. 1999. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of JUN N-terminal kinase and failureof prednisolonetoinhibit JUN N-terminal kinase phosphorylation. J Allergy Clin Immunol 104:565-574. http://dx.doi.org/10.1016/S0091-6749 (99) 70325-8.
106. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M. 1990. Transcriptional interference between c-Jun. and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215. http://dx.doi.org/10.1016/0092-8674 (90) 90396-V.
107. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. 1990. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272. http://dx.doi.org/10.1126/science.2119054.
108. Biddie SC, John S, Sabo PJ, Thurman RE, Johnson TA, Schiltz RL, Miranda TB, Sung MH, Trump S, Lightman SL, Vinson C, Stamatoyannopoulos JA, Hager GL. 2011. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell 43:145-155. http://dx.doi.org/10.1016/j.molcel.2011.06.016.
109. Biddie SC, Conway-Campbell BL, Lightman SL. 2012. Dynamic regulation of glucocorticoid signalling in health and disease. Rheumatology (Oxford) 51:403-412. http://dx.doi.org/10.1093/rheumatology/ker215.
110. Bruna A, Nicolas M, Munoz A, Kyriakis JM, Caelles C. 2003. Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J 22:6035-6044. http://dx.doi.org/10.1093/emboj/cdg590.
111. Barnes PJ. 2006. Corticosteroid effects on cell signalling. Eur Respir J 27:413-426. http://dx.doi.org/10.1183/09031936.06.00125404.
112. Davies L, Karthikeyan N, Lynch JT, Sial EA, Gkourtsa A, Demonacos C, Krstic-Demonacos M. 2008. Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function. Mol Endocrinol 22:1331-1344. http://dx.doi.org/10.1210/me.2007-0360.
113. Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB. 2005. p38 mitogen-activated protein kinase (MAPK) is a key mediatoringlucocorticoid-induced apoptosisoflymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19:1569-1583. http://dx.doi.org/10.1210/me.2004-0528.
114. Itoh M, Adachi M, Yasui H, Takekawa M, Tanaka H, Imai K. 2002. Nuclear export of glucocorticoid receptor is enhanced by c-Jun. N-terminal kinase-mediated phosphorylation. Mol Endocrinol 16:2382-2392. http://dx.doi.org/10.1210/me.2002-0144.
115. Beck IM, Vanden Berghe W, Vermeulen L, Bougarne N, Vander Cruyssen B, Haegeman G, De Bosscher K. 2008. Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition. EMBO J 27:1682-1693. http://dx.doi.org/10.1038/emboj.2008.95.
116. Widen C, Zilliacus J, Gustafsson JA, Wikstrom AC. 2000. Glucocorticoid receptor interaction with 14-3-3 and Raf-1, a proposed mechanism for cross-talk of two signal transduction pathways. J Biol Chem 275:39296-39301. http://dx.doi.org/10.1074/jbc. M006943200.
117. Gutierrez-Mecinas M, Trollope AF, Collins A, Morfett H, Hesketh SA, Kersante F, Reul JM. 2011. Long-lasting behavioral responses to stress involve a direct interaction of glucocorticoid receptors with ERK1/2-MSK1-Elk-1 signaling. Proc Natl Acad Sci U S A 108:13806-13811. http://dx.doi.org/10.1073/pnas.1104383108.
118. Vandevyver S, Dejager L, Tuckermann J, Libert C. 2013. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology 154:993-1007. http://dx.doi.org/10.1210/en. 2012-2045.
119. Oitzl MS, Reichardt HM, Joels M, de Kloet ER. 2001. Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc Natl Acad Sci U SA 98:12790-12795. http://dx.doi.org/10.1073/pnas.231313998.
120. Baschant U, Frappart L, Rauchhaus U, Bruns L, Reichardt HM, Kamradt T, Brauer R, Tuckermann JP. 2011. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc Natl Acad Sci U S A 108:19317-19322. http://dx.doi.org/10.1073/pnas.1105857108.
121. Kleiman A, Hubner S, Rodriguez Parkitna JM, Neumann A, Hofer S, Weigand MA, Bauer M, Schmid W, Schutz G, Libert C, Reichardt HM, Tuckermann JP. 2012. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J 26:722-729. http://dx.doi.org/10.1096/fj.11-192112.
122. Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A, Clausen BE, Stride B, Forster I, Habenicht AJ, Reichardt HM, Tronche F, Schmid W, Schutz G. 2007. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest 117:1381-1390. http://dx.doi.org/10.1172/JCI28034.
123. Vandevyver S, Dejager L, Van Bogaert T, Kleyman A, Liu Y, Tuckermann J, Libert C. 2012. Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. J Clin Invest 122:2130-2140. http://dx.doi.org/10.1172/JCI60006.
124. Yu H, Li Q, Herbert B, Zinna R, Martin K, Junior CR, Kirkwood KL. 2011. Anti-inflammatory effect of MAPK phosphatase-1 local gene transferin inflammatory bone loss. Gene Ther 18:344-353. http://dx.doi.org/10.1038/gt.2010.139.
125. Abraham SM, Clark AR. 2006. Dual-specificity phosphatase 1: a critical regulator of innate immune responses. Biochem Soc Trans 34:1018-1023. http://dx.doi.org/10.1042/BST0341018.
126. Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, Saklatvala J, Clark AR. 2006. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 203:1883-1889. http://dx.doi.org/10.1084/jem.20060336.
127. Riccardi C. 2010. GILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoids. Ann Ig 22:53-59. (In Italian.).
128. Eddleston J, Herschbach J, Wagelie-Steffen AL, Christiansen SC, Zuraw BL. 2007. The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol 119:115-122. http://dx.doi.org/10.1016/j.jaci.2006.08.027.
129. Perretti M, D'Acquisto F. 2009. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9:62-70. http://dx.doi.org/10.1038/nri2470.
130. Damazo AS, Sampaio AL, Nakata CM, Flower RJ, Perretti M, Oliani SM. 2011. Endogenous annexin A1 counter-regulates bleomycininduced lung fibrosis. BMC Immunol 12:59. http://dx.doi.org/10.1186/1471-2172-12-59.
131. Yang YH, Morand EF, Getting SJ, Paul-Clark M, Liu DL, Yona S, Hannon R, Buckingham JC, Perretti M, Flower RJ. 2004. Modulation of inflammation and response to dexamethasone by annexin 1 in antigen-induced arthritis. Arthritis Rheum 50:976-984. http://dx.doi.org/10.1002/art.20201.
132. Vong L, Ferraz JG, Dufton N, Panaccione R, Beck PL, Sherman PM, Perretti M, Wallace JL. 2012. Up-regulation of annexin-A1 and lipoxin A (4) in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS One 7:e39244. http://dx.doi.org/10.1371/journal.pone.0039244.
133. Oakley RH, Sar M, Cidlowski JA. 1996. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem 271:9550-9559.
134. Diaz PV, Pinto RA, Mamani R, Uasapud PA, Bono MR, Gaggero AA, Guerrero J, Goecke A. 2012. Increased expression of the glucocorticoid receptor beta in infants with RSV bronchiolitis. Pediatrics 130:e804-e811. http://dx.doi.org/10.1542/peds.2012-0160.
135. Taniguchi Y, Iwasaki Y, Tsugita M, Nishiyama M, Taguchi T, Okazaki M, Nakayama S, Kambayashi M, Hashimoto K, Terada Y. 2010. Glucocorticoid receptor-beta and receptor-gamma exert dominant negative effect on gene repression but not on gene induction. Endocrinology 151:3204-3213. http://dx.doi.org/10.1210/en. 2009-1254.
136. Strickland I, Kisich K, Hauk PJ, Vottero A, Chrousos GP, Klemm DJ, Leung DY. 2001. High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 193:585-593. http://dx.doi.org/10.1084/jem.193.5.585.
137. Nie M, Corbett L, Knox AJ, Pang L. 2005. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. J Biol Chem 280:2550-2561. http://dx.doi.org/10.1074/jbc. M410616200.
138. Lahiri S, Sen T, Palit G. 2009. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats. Eur J Pharmacol 609:118-125. http://dx.doi.org/10.1016/j.ejphar.2009.03.005.
139. Bougarne N, Paumelle R, Caron S, Hennuyer N, Mansouri R, Gervois P, Staels B, Haegeman G, De Bosscher K. 2009. PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB. Proc Natl Acad Sci U S A 106:7397-7402. http://dx.doi.org/10.1073/pnas.0806742106.
140. Nader N, Ng SS, Wang Y, Abel BS, Chrousos GP, Kino T. 2012. Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism. PLoS One 7:e26751. http://dx.doi.org/10.1371/journal.pone.0026751.
141. Toth K, Sarang Z, Scholtz B, Brazda P, Ghyselinck N, Chambon P, Fesus L, Szondy Z. 2011. Retinoids enhance glucocorticoid-induced apoptosis of T cells by facilitating glucocorticoid receptor-mediated transcription. Cell Death Differ 18:783-792. http://dx.doi.org/10.1038/cdd.2010.136.
142. Demirpence E, Semlali A, Oliva J, Balaguer P, Badia E, Duchesne MJ, Nicolas JC, Pons M. 2002. An estrogen-responsive element-targeted histone deacetylase enzyme has an antiestrogen activity that differs from that of hydroxytamoxifen. Cancer Res 62:6519-6528.
143. Lei K, Chen L, Georgiou EX, Sooranna SR, Khanjani S, Brosens JJ, Bennett PR, Johnson MR. 2012. Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1beta-induced COX-2 expression in human term myometrial cells. PLoS One 7:e50167. http://dx.doi.org/10.1371/journal.pone.0050167.
144. Chen S, Wang J, Yu G, Liu W, Pearce D. 1997. Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity. J Biol Chem 272:14087-14092.
145. Lu Y, Zhang Z, Xiong X, Wang X, Li J, Shi G, Yang J, Zhang X, Zhang H, Hong J, Xia X, Ning G, Li X. 2012. Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid X receptor. Gastroenterology 143:1630-1640. http://dx.doi.org/10.1053/j.gastro.2012.08.029.
146. Renga B, Mencarelli A, D'Amore C, Cipriani S, Baldelli F, Zampella A, Distrutti E, Fiorucci S. 2012. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. FASEB J 26:3021-3031. http://dx.doi.org/10.1096/fj.11-195701.
147. Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W. 2008. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 48:1632-1643. http://dx.doi.org/10.1002/hep. 22519.
148. Bolt MJ, Stossi F, Newberg JY, Orjalo A, Johansson HE, Mancini MA. 2013. Coactivators enable glucocorticoid receptor recruitment to finetune estrogen receptor transcriptional responses. Nucleic Acids Res 41:4036-4048. http://dx.doi.org/10.1093/nar/gkt100.
149. Planey SL, Derfoul A, Steplewski A, Robertson NM, Litwack G. 2002. Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain. J Biol Chem 277:42188-42196. http://dx.doi.org/10.1074/jbc. M205085200.
150. Chantong B, Kratschmar DV, Nashev LG, Balazs Z, Odermatt A. 2012. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. J Neuroinflammation 9:260. http://dx.doi.org/10.1186/1742-2094-9-260.
151. Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J, Assmus HE, Andrade-Navarro MA, Wanker EE. 2011. A directed protein interaction network for investigating intracellular signal transduction. Sci Signal 4: rs8. http://dx.doi.org/10.1126/scisignal.2001699.
152. Martens C, Bilodeau S, Maira M, Gauthier Y, Drouin J. 2005. Proteinprotein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol Endocrinol 19:885-897. http://dx.doi.org/10.1210/me.2004-0333.
153. Philips A, Maira M, Mullick A, Chamberland M, Lesage S, Hugo P, Drouin J. 1997. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol Cell Biol 17:5952-5959. http://dx.doi.org/10.1128/MCB.17.10.5952.
154. Zhou J, Oakley RH, Cidlowski JA. 2008. DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner. Mol Endocrinol 22:1521-1534. http://dx.doi.org/10.1210/me.2007-0273.
155. Icardi L, Mori R, Gesellchen V, Eyckerman S, De Cauwer L, Verhelst J, Vercauteren K, Saelens X, Meuleman P, Leroux-Roels G, De Bosscher K, Boutros M, Tavernier J. 2012. The Sin3a repressor complex is a master regulator of STAT transcriptional activity. Proc Natl Acad Sci U S A 109:12058-12063. http://dx.doi.org/10.1073/pnas.1206458109.
156. Park C, Li S, Cha E, Schindler C. 2000. Immune response in Stat2 knockout mice. Immunity 13:795-804. http://dx.doi.org/10.1016/S1074-7613 (00) 00077-7.
157. Haffner MC, Jurgeit A, Berlato C, Geley S, Parajuli N, Yoshimura A, Doppler W. 2008. Interaction and functional interference of glucocorticoid receptor and SOCS1. J Biol Chem 283:22089-22096. http://dx.doi.org/10.1074/jbc. M801041200.
158. De Miguel F, Lee SO, Onate SA, Gao AC. 2003. Stat3 enhances transactivation of steroid hormone receptors. Nucl Recept 1:3. http://dx.doi.org/10.1186/1478-1336-1-3.
159. Zhang Z, Jones S, Hagood JS, Fuentes NL, Fuller GM. 1997. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem 272:30607-30610. http://dx.doi.org/10.1074/jbc.272.49.30607.
160. Arambasic J, Poznanovic G, Ivanovic-Matic S, Bogojevic D, Mihailovic M, Uskokovic A, Grigorov I. 2010. Association of the glucocorticoid receptor with STAT3, C/EBPbeta, and the hormone-responsive element within the rat haptoglobin gene promoter during the acute phase response. IUBMB Life 62:227-236. http://dx.doi.org/10.1002/iub.313.
161. Langlais D, Couture C, Balsalobre A, Drouin J. 2012. The Stat3/GR interaction code: predictive value ofdirect/indirect DNA recruitment for transcription outcome. Mol Cell 47:38-49. http://dx.doi.org/10.1016/j.molcel.2012.04.021.
162. Stoecklin E, Wissler M, Moriggl R, Groner B. 1997. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol Cell Biol 17:6708-6716. http://dx.doi.org/10.1128/MCB.17.11.6708.
163. Biola A, Lefebvre P, Perrin-Wolff M, Sturm M, Bertoglio J, Pallardy M. 2001. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1. Mol Endocrinol 15:1062-1076. http://dx.doi.org/10.1210/mend.15.7.0657.
164. Lechner J, Welte T, Doppler W. 1997. Mechanism of interaction between the glucocorticoid receptor and Stat5: role of DNA-binding. Immunobiology 198:112-123. http://dx.doi.org/10.1016/S0171-2985 (97) 80032-0.
165. Wyszomierski SL, Yeh J, Rosen JM. 1999. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol Endocrinol 13:330-343. http://dx.doi.org/10.1210/mend.13.2.0232.
166. Engblom D, Kornfeld JW, Schwake L, Tronche F, Reimann A, Beug H, Hennighausen L, Moriggl R, Schutz G. 2007. Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev 21:1157-1162. http://dx.doi.org/10.1101/gad.426007.
167. Shuto T, Imasato A, Jono H, Sakai A, Xu H, Watanabe T, Rixter DD, Kai H, Andalibi A, Linthicum F, Guan YL, Han J, Cato AC, Lim DJ, Akira S, Li JD. 2002. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem 277:17263-17270. http://dx.doi.org/10.1074/jbc. M112190200.
168. Hermoso MA, Matsuguchi T, Smoak K, Cidlowski JA. 2004. Glucocorticoids and tumor necrosis factor alpha cooperatively regulate Tolllike receptor 2 gene expression. Mol Cell Biol 24:4743-4756. http://dx.doi.org/10.1128/MCB.24.11.4743-4756.2004.
169. Guo L, Lichten LA, Ryu MS, Liuzzi JP, Wang F, Cousins RJ. 2010. STAT5-glucocorticoid receptor interaction and MTF-1 regulate the expression of ZnT2 (Slc30a2) in pancreatic acinar cells. Proc Natl Acad Sci U S A 107:2818-2823. http://dx.doi.org/10.1073/pnas.0914941107.
170. Foster M, Samman S. 2012. Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients 4:676-694. http://dx.doi.org/10.3390/nu4070676.
171. Liu MJ, Bao S, Galvez-Peralta M, Pyle CJ, Rudawsky AC, Pavlovicz RE, Killilea DW, Li C, Nebert DW, Wewers MD, Knoell DL. 2013. ZIP8 regulates host defense through zinc-mediated inhibition of NF-kappaB. Cell Rep 3:386-400. http://dx.doi.org/10.1016/j.celrep. 2013.01.009.
172. Moras D, Gronemeyer H. 1998. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 10:384-391. http://dx.doi.org/10.1016/S0955-0674 (98) 80015-X.
173. Glass CK, Rosenfeld MG. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141.
174. Llopis J, Westin S, Ricote M, Wang Z, Cho CY, Kurokawa R, Mullen TM, Rose DW, Rosenfeld MG, Tsien RY, Glass CK. 2000. Liganddependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription. Proc Natl Acad Sci U S A 97:4363-4368. http://dx.doi.org/10.1073/pnas.97.8.4363.
175. Onate SA, Tsai SY, Tsai MJ, O'Malley BW. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357. http://dx.doi.org/10.1126/science.270.5240.1354.
176. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR. 1996. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci U S A 93:4948-4952. http://dx.doi.org/10.1073/pnas.93.10.4948.
177. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968. http://dx.doi.org/10.1126/science.277.5328.965.
178. Lee SK, Anzick SL, Choi JE, Bubendorf L, Guan XY, Jung YK, Kallioniemi OP, Kononen J, Trent JM, Azorsa D, Jhun BH, Cheong JH, Lee YC, Meltzer PS, Lee JW. 1999. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for liganddependent transactivation by nuclear receptors in vivo. J Biol Chem 274:34283-34293. http://dx.doi.org/10.1074/jbc.274.48.34283.
179. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 12:3357-3368. http://dx.doi.org/10.1101/gad.12.21.3357.
180. Heery DM, Kalkhoven E, Hoare S, Parker MG. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-736. http://dx.doi.org/10.1038/42750.
181. Feng W, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, Fletterick RJ, Baxter JD, Kushner PJ, West BL. 1998. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280:1747-1749. http://dx.doi.org/10.1126/science.280.5370.1747.
182. Marmorstein R. 2001. Structure of histone deacetylases: insights into substrate recognition and catalysis. Structure 9:1127-1133. http://dx.doi.org/10.1016/S0969-2126 (01) 00690-6.
183. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324. http://dx.doi.org/10.1038/382319a0.
184. Li X, Wong J, Tsai SY, Tsai MJ, O'Malley BW. 2003. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol Cell Biol 23:3763-3773. http://dx.doi.org/10.1128/MCB.23.11.3763-3773.2003.
185. Chinenov Y, Gupte R, Dobrovolna J, Flammer JR, Liu B, Michelassi FE, Rogatsky I. 2012. Role of transcriptional coregulator GRIP1 in the anti-inflammatory actions of glucocorticoids. Proc Natl Acad Sci U S A 109:11776-11781. http://dx.doi.org/10.1073/pnas.1206059109.
186. Bhandare R, Damera G, Banerjee A, Flammer JR, Keslacy S, Rogatsky I, Panettieri RA, Amrani Y, Tliba O. 2010. Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroidresistant airway structural cells. Am J Respir Cell Mol Biol 42:9-15. http://dx.doi.org/10.1165/rcmb.2009-0239RC.
187. Sheppard KA, Phelps KM, Williams AJ, Thanos D, Glass CK, Rosenfeld MG, Gerritsen ME, Collins T. 1998. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 273:29291-29294. http://dx.doi.org/10.1074/jbc.273.45.29291.
188. De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, Haegeman G. 2000. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A 97:3919-3924. http://dx.doi.org/10.1073/pnas.97.8.3919.
189. Rogatsky I, Zarember KA, Yamamoto KR. 2001. Factor recruitment and TIF2/GRIP1 corepressor activity at acollagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J 20:6071-6083. http://dx.doi.org/10.1093/emboj/20.21.6071.
190. Dobrovolna J, Chinenov Y, Kennedy MA, Liu B, Rogatsky I. 2012. Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1. Mol Cell Biol 32:730-739. http://dx.doi.org/10.1128/MCB.06473-11.
191. Avenant C, Kotitschke A, Hapgood JP. 2010. Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment. Biochemistry 49:972-985. http://dx.doi.org/10.1021/bi901956s.
192. Gupte R, Muse GW, Chinenov Y, Adelman K, Rogatsky I. 2013. Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle. Proc Natl Acad Sci U S A 110:14616-14621. http://dx.doi.org/10.1073/pnas.1309898110.
193. Reily MM, Pantoja C, Hu X, Chinenov Y, Rogatsky I. 2006. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J 25:108-117. http://dx.doi.org/10.1038/sj.emboj.7600919.
194. Kino T, Chrousos GP. 2003. Tumor necrosis factor alpha receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators. JBiol Chem 278:3023-3029. http://dx.doi.org/10.1074/jbc. M209234200.
195. Obradovic D, Tirard M, Nemethy Z, Hirsch O, Gronemeyer H, Almeida OF. 2004. DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells-toward a basis for the opposite actions elicited by two nuclear receptors? Mol Pharmacol 65:761-769. http://dx.doi.org/10.1124/mol.65.3.761.
196. Almlof T, Wallberg AE, Gustafsson JA, Wright AP. 1998. Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors. Biochemistry 37:9586-9594. http://dx.doi.org/10.1021/bi973029x.
197. Kino T, Nordeen SK, Chrousos GP. 1999. Conditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300. J Steroid Biochem Mol Biol 70:15-25. http://dx.doi.org/10.1016/S0960-0760 (99) 00100-4.
198. Ramos RA, Meilandt WJ, Wang EC, Firestone GL. 1999. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant. FASEB J 13:169-180.
199. Boruk M, Savory JG, Hache RJ. 1998. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor. Mol Endocrinol 12:1749-1763. http://dx.doi.org/10.1210/mend.12.11.0191.
200. Christian M, Pohnke Y, Kempf R, Gellersen B, Brosens JJ. 2002. Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. Mol Endocrinol 16:141-154. http://dx.doi.org/10.1210/mend.16.1.0763.
201. Dhawan P, Christakos S. 2010. Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24 (OH) ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBP beta, and the vitamin D receptor in 24 (OH) ase transcription. J Cell Biochem 110:1314-1323. http://dx.doi.org/10.1002/jcb.22645.
202. Garza AS, Khan SH, Moure CM, Edwards DP, Kumar R. 2011. Binding-folding induced regulation of AF1 transactivation domain of the glucocorticoid receptor by a cofactor that binds to its DNA binding domain. PLoS One 6:e25875. http://dx.doi.org/10.1371/journal.pone.0025875.
203. Khan SH, Ling J, Kumar R. 2011. TBP binding-induced folding of the glucocorticoid receptor AF1 domain facilitates its interaction with steroid receptor coactivator-1. PLoS One 6:e21939. http://dx.doi.org/10.1371/journal.pone.0021939.
204. Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis C, Hanson J, Meij B, Drouin J. 2006. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev 20:2871-2886. http://dx.doi.org/10.1101/gad.1444606.
205. Nie Z, Xue Y, Yang D, Zhou S, Deroo BJ, Archer TK, Wang W. 2000. A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol 20:8879-8888. http://dx.doi.org/10.1128/MCB.20.23.8879-8888.2000.
206. Hsiao PW, Fryer CJ, Trotter KW, Wang W, Archer TK. 2003. BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation. Mol Cell Biol 23:6210-6220. http://dx.doi.org/10.1128/MCB.23.17.6210-6220.2003.
207. Fletcher TM, Xiao N, Mautino G, Baumann CT, Wolford R, Warren BS, Hager GL. 2002. ATP-dependent mobilization of the glucocorticoid receptor during chromatin remodeling. Mol Cell Biol 22:3255-3263. http://dx.doi.org/10.1128/MCB.22.10.3255-3263.2002.
208. Kino T, Gragerov A, Kopp JB, Stauber RH, Pavlakis GN, Chrousos GP. 1999. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J Exp Med 189:51-62. http://dx.doi.org/10.1084/jem.189.1.51.
209. Kino T, Slobodskaya O, Pavlakis GN, Chrousos GP. 2002. Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J Biol Chem 277:2396-2405. http://dx.doi.org/10.1074/jbc. M106312200.
210. Kino T, Gragerov A, Slobodskaya O, Tsopanomichalou M, Chrousos GP, Pavlakis GN. 2002. Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoidresponsive promoters by binding directly to p300/CBP coactivators. J Virol 76:9724-9734. http://dx.doi.org/10.1128/JVI.76.19.9724-9734.2002.
211. Mirani M, Elenkov I, Volpi S, Hiroi N, Chrousos GP, Kino T. 2002. HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implicationsof Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 169:6361-6368. http://dx.doi.org/10.4049/jimmunol.169.11.6361.
212. Kino T, Kopp JB, Chrousos GP. 2000. Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell typespecific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology. J Steroid Biochem Mol Biol 75:283-290. http://dx.doi.org/10.1016/S0960-0760 (00) 00187-4.
213. Collingwood TN, Urnov FD, Wolffe AP. 1999. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol 23:255-275. http://dx.doi.org/10.1677/jme.0.0230255.
214. Schulz M, Eggert M, Baniahmad A, Dostert A, Heinzel T, Renkawitz R. 2002. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding. J Biol Chem 277:26238-26243. http://dx.doi.org/10.1074/jbc. M203268200.
215. Stevens A, Garside H, Berry A, Waters C, White A, Ray D. 2003. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735. Mol Endocrinol 17:845-859. http://dx.doi.org/10.1210/me.2002-0320.
216. Ramamoorthy S, Cidlowski JA. 2013. Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements. Mol Cell Biol 33:1711-1722. http://dx.doi.org/10.1128/MCB.01151-12.
217. Zilliacus J, Holter E, Wakui H, Tazawa H, Treuter E, Gustafsson JA. 2001. Regulation of glucocorticoid receptor activity by 14-3-3-dependent intracellular relocalization of the corepressor RIP140. Mol Endocrinol 15:501-511. http://dx.doi.org/10.1210/mend.15.4.0624.
218. Leite RS, Brown AG, Strauss JF, III. 2004. Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributingtochangesin steroid hormone responsiveness. FASEB J 18:1418-1420.
219. Chen N, Baudino T, MacDonald PN, Green M, Kelley WL, Burnett JW, Buller RM. 2000. Selective inhibition of nuclear steroid receptor function by a protein from a human tumorigenic poxvirus. Virology 274:17-25. http://dx.doi.org/10.1006/viro.2000.0410.
220. Webster Marketon JI, Corry J, Teng MN. 2014. The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation. Virology 449:62-69. http://dx.doi.org/10.1016/j.virol.2013.11.014.
221. Werlen G, Palmer E. 2002. The T-cell receptor signalosome: a dynamic structure with expanding complexity. Curr Opin Immunol 14:299-305. http://dx.doi.org/10.1016/S0952-7915 (02) 00339-4.
222. Nel AE. 2002. T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol 109:758-770.
223. Lowenberg M, Verhaar AP, van den Brink GR, Hommes DW. 2007. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol Med 13:158-163. http://dx.doi.org/10.1016/j.molmed.2007.02.001.
224. Lowenberg M, Verhaar AP, Bilderbeek J, Marle J, Buttgereit F, Peppelenbosch MP, van Deventer SJ, Hommes DW. 2006. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep 7:1023-1029. http://dx.doi.org/10.1038/sj.embor.7400775.
225. Migliorati G, Nicoletti I, D'Adamio F, Spreca A, Pagliacci C, Riccardi C. 1994. Dexamethasone induces apoptosis in mouse natural killer cells and cytotoxic T lymphocytes. Immunology 81:21-26.
226. Meagher LC, Cousin JM, Seckl JR, Haslett C. 1996. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156:4422-4428.
227. Bansal N, Houle A, Melnykovych G. 1991. Apoptosis: mode of cell death induced in T cell leukemia lines by dexamethasone and other agents. FASEB J 5:211-216.
228. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. 1998. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274-282.
229. Wyllie AH. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556. http://dx.doi.org/10.1038/284555a0.
230. Marchetti MC, Di Marco B, Cifone G, Migliorati G, Riccardi C. 2003. Dexamethasone-induced apoptosisof thymocytes: role ofglucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 101:585-593. http://dx.doi.org/10.1182/blood-2002-06-1779.
231. Zhu J, Yamane H, Paul WE. 2010. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28:445-489. http://dx.doi.org/10.1146/annurev-immunol-030409-101212.
232. Liberman AC, Druker J, Refojo D, Holsboer F, Arzt E. 2009. Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB J 23:1558-1571. http://dx.doi.org/10.1096/fj.08-121236.
233. Liberman AC, Refojo D, Druker J, Toscano M, Rein T, Holsboer F, Arzt E. 2007. The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J 21:1177-1188. http://dx.doi.org/10.1096/fj.06-7452com.
234. Chen R, Burke TF, Cumberland JE, Brummet M, Beck LA, Casolaro V, Georas SN. 2000. Glucocorticoids inhibit calcium- and calcineurindependent activation of the human IL-4 promoter. J Immunol 164:825-832. http://dx.doi.org/10.4049/jimmunol.164.2.825.
235. Chang TJ, Scher BM, Waxman S, Scher W. 1993. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol Endocrinol 7:528-542. http://dx.doi.org/10.1210/mend.7.4.8502237.
236. Waghabi MC, Keramidas M, Bailly S, Degrave W, Mendonca-Lima L, Soeiro M D N C, Meirelles M D N L, Paciornik S, Araujo-Jorge TC, Feige JJ. 2005. Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role inparasite cycle completion. Am J Pathol 167:993-1003. http://dx.doi.org/10.1016/S0002-9440 (10) 61189-3.
237. Barral A, Barral-Netto M, Yong EC, Brownell CE, Twardzik DR, Reed SG. 1993. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci U S A 90:3442-3446. http://dx.doi.org/10.1073/pnas.90.8.3442.
238. Barral A, Teixeira M, Reis P, Vinhas V, Costa J, Lessa H, Bittencourt AL, Reed S, Carvalho EM, Barral-Netto M. 1995. Transforming growth factor-beta in human cutaneous leishmaniasis. Am J Pathol 147:947-954.
239. Lotz M, Seth P. 1993. TGF beta and HIV infection. Ann N Y Acad Sci 685:501-511. http://dx.doi.org/10.1111/j.1749-6632.1993.tb35912.x.
240. Machold KP, Carson DA, Lotz M. 1993. Transforming growth factor-beta (TGF beta) inhibition of Epstein-Barr virus (EBV) - and interleukin-4 (IL-4)-induced immunoglobulin production in human B lymphocytes. J Clin Immunol 13:219-227. http://dx.doi.org/10.1007/BF00919975.
241. Wan YY, Flavell RA. 2007. 'Yin-yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol Rev 220:199-213. http://dx.doi.org/10.1111/j.1600-065X.2007.00565.x.
242. Song CZ, Tian X, Gelehrter TD. 1999. Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc Natl Acad Sci U S A 96:11776-11781. http://dx.doi.org/10.1073/pnas.96.21.11776.
243. Aurrekoetxea-Hernandez K, Buetti E. 2004. Transforming growth factor beta enhances the glucocorticoid response of the mouse mammary tumor virus promoter through Smad and GA-binding proteins. J Virol 78:2201-2211. http://dx.doi.org/10.1128/JVI.78.5.2201-2211.2004.
244. Ichijo T, Voutetakis A, Cotrim AP, Bhattachryya N, Fujii M, Chrousos GP, Kino T. 2005. The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications. J Biol Chem 280:42067-42077. http://dx.doi.org/10.1074/jbc. M509338200.
245. Muromoto R, Sugiyama K, Yamamoto T, Oritani K, Shimoda K, Matsuda T. 2004. Physical and functional interactions between Daxx and TSG101. Biochem Biophys Res Commun 316:827-833. http://dx.doi.org/10.1016/j.bbrc.2004.02.126.
246. Lin DY, Lai MZ, Ann DK, Shih HM. 2003. Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxxtothe PML oncogenic domains (PODs) to enhance its transactivation potential. J Biol Chem 278:15958-15965. http://dx.doi.org/10.1074/jbc. M300387200.
247. Lin DY, Huang YS, Jeng JC, Kuo HY, Chang CC, Chao TT, Ho CC, Chen YC, Lin TP, Fang HI, Hung CC, Suen CS, Hwang MJ, Chang KS, Maul GG, Shih HM. 2006. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell 24:341-354. http://dx.doi.org/10.1016/j.molcel.2006.10.019.
248. Galliher-Beckley AJ, Cidlowski JA. 2009. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease. IUBMB Life 61:979-986. http://dx.doi.org/10.1002/iub.245.
249. Ismaili N, Garabedian MJ. 2004. Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci 1024:86-101. http://dx.doi.org/10.1196/annals.1321.007.
250. Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ. 1997. Mitogenactivated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 17:3947-3954. http://dx.doi.org/10.1128/MCB.17.7.3947.
251. Wang Z, Frederick J, Garabedian MJ. 2002. Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. J Biol Chem 277:26573-26580. http://dx.doi.org/10.1074/jbc. M110530200.
252. Kino T, Ichijo T, Amin ND, Kesavapany S, Wang Y, Kim N, Rao S, Player A, Zheng YL, Garabedian MJ, Kawasaki E, Pant HC, Chrousos GP. 2007. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol 21:1552-1568. http://dx.doi.org/10.1210/me.2006-0345.
253. Poolman TM, Farrow SN, Matthews L, Loudon AS, Ray DW. 2013. Pin1 promotes GR transactivation by enhancing recruitment to target genes. Nucleic Acids Res 41:8515-8525. http://dx.doi.org/10.1093/nar/gkt624.
254. Giffin W, Kwast-Welfeld J, Rodda DJ, Prefontaine GG, Traykova-Andonova M, Zhang Y, Weigel NL, Lefebvre YA, Hache RJ. 1997. Sequence-specific DNA binding and transcription factor phosphorylation by Ku autoantigen/DNA-dependent protein kinase. Phosphorylation of Ser-527 of the rat glucocorticoid receptor. J Biol Chem 272:5647-5658.
255. Bouazza B, Krytska K, Debba-Pavard M, Amrani Y, Honkanen RE, Tran J, Tliba O. 2012. Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases. Am J Respir Cell Mol Biol 47:464-473. http://dx.doi.org/10.1165/rcmb.2011-0364OC.
256. Li MD, Ruan HB, Singh JP, Zhao L, Zhao T, Azarhoush S, Wu J, Evans RM, Yang X. 2012. O-GlcNAc transferase is involved in glucocorticoid receptor-mediated transrepression. J Biol Chem 287:12904-12912. http://dx.doi.org/10.1074/jbc. M111.303792.
257. Nader N, Chrousos GP, Kino T. 2009. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J 23:1572-1583. http://dx.doi.org/10.1096/fj.08-117697.
258. Jee YK, Gilmour J, Kelly A, Bowen H, Richards D, Soh C, Smith P, Hawrylowicz C, Cousins D, Lee T, Lavender P. 2005. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment. J Biol Chem 280:23243-23250. http://dx.doi.org/10.1074/jbc. M503659200.
259. Qiu Y, Zhao Y, Becker M, John S, Parekh BS, Huang S, Hendarwanto A, Martinez ED, Chen Y, Lu H, Adkins NL, Stavreva DA, Wiench M, Georgel PT, Schiltz RL, Hager GL. 2006. HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell 22:669-679. http://dx.doi.org/10.1016/j.molcel.2006.04.019.
260. Bush KA, Krukowski K, Eddy JL, Janusek LW, Mathews HL. 2012. Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules. Cell Immunol 275:80-89. http://dx.doi.org/10.1016/j.cellimm.2012.02.014.
261. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM. 2006. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203:7-13. http://dx.doi.org/10.1084/jem.20050466.
262. Ito K, Barnes PJ, Adcock IM. 2000. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation onlysines 8and 12. Mol Cell Biol 20:6891-6903. http://dx.doi.org/10.1128/MCB.20.18.6891-6903.2000.
263. Fernandes I, Bastien Y, Wai T, Nygard K, Lin R, Cormier O, Lee HS, Eng F, Bertos NR, Pelletier N, Mader S, Han VK, Yang XJ, White JH. 2003. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol Cell 11:139-150. http://dx.doi.org/10.1016/S1097-2765 (03) 00014-5.
264. Druker J, Liberman AC, Antunica-Noguerol M, Gerez J, Paez-Pereda M, Rein T, Iniguez-Lluhi JA, Holsboer F, Arzt E. 2013. RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity. Mol Cell Biol 33:2116-2127. http://dx.doi.org/10.1128/MCB.01470-12.
265. Paakinaho V, Kaikkonen S, Makkonen H, Benes V, Palvimo JJ. 4 November 2013. SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor. Nucleic Acids Res http://dx.doi.org/10.1093/nar/gkt1033.
266. Guo D, Han J, Adam BL, Colburn NH, Wang MH, Dong Z, Eizirik DL, She JX, Wang CY. 2005. Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochem Biophys Res Commun 337:1308-1318. http://dx.doi.org/10.1016/j.bbrc.2005.09.191.
267. Verma S, Ismail A, Gao X, Fu G, Li X, O'Malley BW, Nawaz Z. 2004. The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors. Mol Cell Biol 24:8716-8726. http://dx.doi.org/10.1128/MCB.24.19.8716-8726.2004.
268. Garside H, Waters C, Berry A, Rice L, Ardley HC, White A, Robinson PA, Ray D. 2006. UbcH7 interacts with the glucocorticoid receptor and mediates receptor autoregulation. J Endocrinol 190:621-629. http://dx.doi.org/10.1677/joe.1.06799.
269. Kaul S, Blackford JA, Jr, Cho S, Simons SS, Jr. 2002. Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors. J Biol Chem 277:12541-12549. http://dx.doi.org/10.1074/jbc. M112330200.
270. Ramamoorthy S, Nawaz Z. 2008. E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors. Nucl Recept Signal 6:e006. http://dx.doi.org/10.1621/nrs.06006.
271. Godavarthi SK, Dey P, Maheshwari M, Jana NR. 2012. Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome. Hum Mol Genet 21:1824-1834. http://dx.doi.org/10.1093/hmg/ddr614.
272. Walsh CA, Qin L, Tien JC, Young LS, Xu J. 2012. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int J Biol Sci 8:470-485. http://dx.doi.org/10.7150/ijbs.4125.
273. Lucafo M, De Iudicibus S, Di Silvestre A, Pelin M, Candussio L, Martelossi S, Tommasini A, Piscianz E, Ventura A, Decorti G. 2015. Long noncoding RNA GAS5: a novel marker involved in glucocorticoid response. Curr Mol Med 15:94-99. http://dx.doi.org/10.2174/1566524015666150114122354.
274. Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP. 2010. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 3: ra8. http://dx.doi.org/10.1126/scisignal.2000568.